Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Kidney Blood Press Res ; 32(3): 210-6, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19590228

RESUMEN

BACKGROUND: Recent studies indicate an increased mortality of anemic patients with renal failure when near-normal hemoglobin levels are aimed for by treatment with erythropoiesis stimulating agents. Aortic pulse wave velocity (aPWV) is a strong predictor of all-cause and cardiovascular mortality in patients with end-stage renal disease. The relationships between aPWV, hemoglobin levels and erythropoiesis stimulating agent dosage have not been evaluated to date. METHODS: In 75 patients, aPWV was measured by applanation tonometry. Associations of aPWV and a broad range of clinical, laboratory and therapeutic parameters were determined by stepwise linear regression analysis. RESULTS: aPWV was positively correlated to age (r = 0.55, p < 0.001), whereas the association with hemoglobin was significant, but negative (r = -0.31, p = 0.01). Multivariate analysis determined age (beta = 0.513, p < 0.001), mean blood pressure (beta = 0.255, p = 0.01), the presence of heart failure (beta = 0.188, p = 0.03), hemoglobin (beta = -0.226, p = 0.01), daily calcium load (beta = -0.230, p = 0.01) and the presence of diabetes mellitus (beta = 0.179, p = 0.04) to have a significant and independent influence on aPWV. CONCLUSIONS: This study demonstrates that in hemodialysis patients, aPWV is significantly but negatively associated with the serum hemoglobin concentration, even after multiple adjustments for other covariates.


Asunto(s)
Anemia/fisiopatología , Fallo Renal Crónico/complicaciones , Flujo Pulsátil , Anciano , Anciano de 80 o más Años , Aorta/fisiología , Femenino , Hemoglobinas/análisis , Humanos , Fallo Renal Crónico/fisiopatología , Masculino , Persona de Mediana Edad , Diálisis Renal , Factores de Riesgo
2.
Mil Med ; 171(6): 484-90, 2006 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-16808125

RESUMEN

Military health care providers located in field environments frequently face situations in which procedural sedation and analgesia are necessary, without the advantage of sophisticated monitoring equipment. Ketamine is a unique agent that can be administered either intravenously or intramuscularly to produce predictable and profound analgesia, with an exceptional safety profile. We review the issues unique to ketamine and provide a practical guide for the use of ketamine for adult and pediatric patients in a field environment.


Asunto(s)
Anestésicos Disociativos/uso terapéutico , Sedación Consciente/métodos , Hospitales Militares , Ketamina/uso terapéutico , Medicina Militar/normas , Personal Militar , Triaje , Adulto , Anestésicos Disociativos/administración & dosificación , Niño , Hospitales de Urgencia , Humanos , Ketamina/administración & dosificación , Medicina Militar/métodos , Medición de Riesgo , Estados Unidos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA